Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000059478-19-000022)

Filing Details

Accession Number:: 0000059478-19-000022
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-02-01 14:38:13
Reporting Period:: 2018-04-13

Accepted Time:: 2019-02-01 14:38:13
Original Submission Date:: 2018-04-17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Lilly Eli & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1463321	Susan Mahony	Lilly Corporate Center Indianapolis IN 46285	Svp & Pres., Lilly Oncology	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-04-16	17,379	$80.08	40,685	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is being filed to correct the total holdings held by the reporting person following the transaction reported on the original Form 4 filed on April 17, 2018.